American Society of Echocardiography (ASE)

The American Society of Echocardiography (ASE) is the key cardiovascular ultrasound medical society. ASE works to advance cardiac ultrasound, offers clinical education, research, government policy advocacy, and services to the professionals and the public.

Video of Maddie Jankowski explaining sonographer highlights and trends at the American Society of Echo (ASE) 2023 meeting.

The rise of AI and other key takeaways for sonographers at ASE 2023

Cardiac sonographer Maddie Jankowski, BS, ACS, RDCS, joined us to explore key trends and updates for sonographers from ASE 2023 in National Harbor, Maryland. 

Axial planes suggested for screening the fetal heart at the time of the obstetric anatomic survey and as an initial series obtained during fetal echocardiography. #Fetalecho

ASE updates fetal echocardiography guidelines

The new 44-page document focuses on the detection, classification and risk assessment of congenital heart issues.

Video of American Society of Echocardiography (ASE) leadership explaining how the society recognized early the need for standardization and training for on and stepped forward to offer training for various point of care ultrasound (POCUS) users and to bring them into its membership. Image shows a critical care COVID patient being scanned with a Philips Lumify point-of-care ultrasound system with doctors on screen helping guide the user. #POCUS #ASE #ASE2023

ASE training clinicians as point-of-care ultrasound grows

The American Society of Echocardiography recognized the lack of training and standardization for point-of-care ultrasound users and decided to do something about it. 

Roosha Parikh, MD, advanced imaging cardiologist, St. Francis Heart Hospital, Long Island, New York, and a clinical assistant professor of medicine at the State University of New York at Stony Brook, presented in one of the ASE 2023 amyloid sessions and spoke with Cardiovascular Business about the disease.

Amyloidosis now a hot topic in cardiac imaging due to new drug treatment

Advanced cardiac imager Roosha Parikh, MD, explained that cardiac amyloidosis is regularly misdiagnosed. It can often be identified in echocardiography results, however, if physicians know how to identify it. 

Stephen Little, MD, discusses trends in echocardiography at ASE 2023. #ASE23 #ASE2023 What is new in cardiac ultrasound.

Back in the spotlight: Exploring echocardiography's revival

American Society of Echocardiography President Stephen Little, MD, says several trends and technologies are coming together at once, leading to renewed interest in echo.

PHOTO GALLERY: The trends and technologies at ASE 2023

Browse through some of the many highlights from the American Society of Echocardiography's 2023 annual meeting. 

Roberto Lang, MD, explains how AI can help novice users get diagnostic quality cardiac echo exams at ASE 2023.#ASE #AI #ASE2023

AI can help novice sonographers deliver optimal echocardiograms

Roberto Lang, MD, has been closely involved with the development of AI technology that helps inexperienced ultrasound users perform high-quality echo exams. "It is an unbelievable thing when you see it working," he said. 

Ted Abraham, MD, explains ASE efforts to increase HCM education and standardization of care. #HCM #ASE #ASE23 #ASE2023

All eyes are on hypertrophic cardiomyopathy now that a drug treatment is in place

Ted Abraham, MD, explained why HCM has entered the limelight at recent cardiology conferences, including ASE 2023.

Around the web

GE HealthCare said the price of iodine contrast increased by more than 200% between 2017 to 2023. Will new Chinese tariffs drive costs even higher?

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.